Jonathan Birchall

Insider Reports History

Location
Malvern, PA
Signature
/s/ John P. Sharp, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Birchall:

Company Role Class Num Shares Value Price $ Report Date Ownership
PhaseBio Pharmaceuticals Inc Chief Commercial Officer Employee Stock Option (right to buy) 52,500 24 Feb 2022 Direct
PhaseBio Pharmaceuticals Inc Chief Commercial Officer Common Stock 20,000 20 May 2022 Direct
PhaseBio Pharmaceuticals Inc Chief Commercial Officer Restricted Stock Unit 11,250 24 Feb 2022 Direct

Insider Reports Filed by Jonathan Birchall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PHASQ PhaseBio Pharmaceuticals Inc 20 May 2022 1 +$13,626 4 Chief Commercial Officer 24 May 2022, 17:13
PHASQ PhaseBio Pharmaceuticals Inc 24 Feb 2022 2 $0 4 Chief Commercial Officer 28 Feb 2022, 18:25
PHASQ PhaseBio Pharmaceuticals Inc 08 Nov 2021 1 +$842,500 4 Chief Commercial Officer 09 Nov 2021, 19:46
PHASQ PhaseBio Pharmaceuticals Inc 08 Nov 2021 0 $0 3 Chief Commercial Officer 09 Nov 2021, 19:45